EUVIMEDEUVIMED entdecken
Crossref

Phytochemical‐Based Drug Discovery for Breast Cancer: Combining Virtual Screening and Molecular Dynamics to Identify Novel Therapeutics

Trupti Pratik Durgawale, V Rajashakar, Jeetendra Kumar Gupta, S Shakila Banu, Sri Hari Galla, Jyoti Singh, A Anka Rao, P Dharani Prasad, Pritam Bhagawat Chaudhari, Mohammad Rakib Mortuza, Sherouk Hussein Sweilam, Mohammed Asiri und 3 weitere

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202402864 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Trupti Pratik Durgawale und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, KVV's Krishna Institute of Pharmacy, Karad, India. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Drug Discovery, Phytochemicals, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Deanship of Scientific Research, King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maternal embryonic leucine zipper kinase (MELK), a pivotal signaling protein, plays a crucial role in various physiological processes, such as cell growth, survival, and differentiation. There is currently a growing interest in MELK as a promising therapeutic target for multiple cancers, including triple‐negative breast cancer (TNBC). Exploring MELK as a target offers a prospective strategy to impede cancer progression and enhance the efficacy of conventional anticancer therapies. In this study, we employed a multistep docking procedure to evaluate the anticancer potential of phyto‐compounds from the NPACT and PhytoHub databases targeting the MELK protein. A collection of 23 740 compounds underwent hierarchical multistep docking, accompanied by an analysis of binding interactions. The extensive analysis identified five compounds (PHUB000697, PHUB002010, NPACT00373, PHUB002005, and PHUB001739) as potent inhibitors of the MELK protein, exhibiting docking scores lower than −11 Kcal/mol, that is, −12.90, −12.00, −11.23, −11.19, and −11.09 Kcal/mol, respectively. PHUB000697 exhibited very crucial interactions with Gly20, Lys40, Cys89, and Glu93 (2.74 Å). To evaluate the stability of protein–ligand interactions in dynamic states, 100 ns molecular dynamics (MD) simulations were conducted using the entire trajectory, revealing a substantial binding affinity for all identified compounds toward the MELK protein. Consequently, these five compounds emerge as promising candidates for future drug development targeting the MELK protein in treating TNBC. However, experimental assessment is essential to understand the molecular interaction mechanisms better. We are aiming to report a few in vitro and in vivo studies on these compounds to validate the computational results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Dynamics SimulationDrug DiscoveryPhytochemicalsProtein Serine-Threonine KinasesProtein Kinase InhibitorsBreast NeoplasmsAntineoplastic Agents, PhytogenicAntineoplastic AgentsHumansMolecular Docking SimulationFemaleDrug Screening Assays, AntitumorMolecular StructureStructure-Activity RelationshipTriple Negative Breast NeoplasmsCell Proliferation

Stichwörter der Autor:innen

breast cancermaternal embryonic leucine zipper kinase (MELK)molecular dynamics (MD) simulationphyto‐compoundsvirtual screening

Substanzen

PhytochemicalsProtein Serine-Threonine KinasesMELK protein, humanProtein Kinase InhibitorsAntineoplastic Agents, PhytogenicAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, KVV's Krishna Institute of Pharmacy, Karad, India.
  • Department of Pharmaceutical Chemistry, Anurag Pharmacy College, Ananthagiri, Suryapet, Telangana, India.
  • Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Mathura, Uttar Pradesh, India.
  • Department of Pharmacognosy, Periyar College of Pharmaceutical Sciences, Tiruchirappalli, Tamil Nadu, India.
  • Medicinal Chemistry Department, University of Louisville, Louisville, Kentucky, USA.
  • School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India.

ORCID-Profile: Biswajit Kumar Utpal

Förderung

  • Deanship of Scientific Research, King Khalid University

Zitieren

APA

Durgawale, T. P., Rajashakar, V., Gupta, J. K., Banu, S. S., Galla, S. H., Singh, J., Rao, A. A., Prasad, P. D., Chaudhari, P. B., Mortuza, M. R., Sweilam, S. H., Asiri, M., Amin, M. A., Utpal, B. K., & Mohammad, B. D. (2025). Phytochemical‐Based Drug Discovery for Breast Cancer: Combining Virtual Screening and Molecular Dynamics to Identify Novel Therapeutics. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402864

Vancouver

Durgawale TP, Rajashakar V, Gupta JK, Banu SS, Galla SH, Singh J, et al. Phytochemical‐Based Drug Discovery for Breast Cancer: Combining Virtual Screening and Molecular Dynamics to Identify Novel Therapeutics. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402864

BibTeX
@article{Durgawale2025,
  author = {Durgawale, Trupti Pratik and Rajashakar, V and Gupta, Jeetendra Kumar and Banu, S Shakila and Galla, Sri Hari and Singh, Jyoti and Rao, A Anka and Prasad, P Dharani and Chaudhari, Pritam Bhagawat and Mortuza, Mohammad Rakib and Sweilam, Sherouk Hussein and Asiri, Mohammed and Amin, Md Al and Utpal, Biswajit Kumar and Mohammad, Badrud Duza},
  title = {Phytochemical‐Based Drug Discovery for Breast Cancer: Combining Virtual Screening and Molecular Dynamics to Identify Novel Therapeutics},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202402864}
}
Kostenlos starten →